Finding and Understanding Clinical Trials
A clinical study examines the effectiveness of new treatments and provides doctors and researchers with data to develop and deliver new, more effective treatments. In a typical year, over one million people participate in clinical studies.
This site provides essential clinical trial information: how medical trials work; your rights as a participant; and learn how signing up for trials can provide access to the best medical facilities and specialists. Participate in a clinical study and you'll help not only yourself, but also the thousands of others who could benefit from the trial's results.
Find a Trial...
You can use this site to find clinical trials by location or by medical condition; see below. Also, by using the search box on the right of this page, you can narrow your search to zip code level.
Current Clinical Trial Listings:Search results for Hemophilia AND Recruiting 1) Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
Hemophilia A
2) Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Unilateral Knee Replacement
Hemophilia A
3) Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
Severe Hemophilia A
4) Gene Transfer for Subjects With Hemophilia B Factor IX Deficiency
Hemophilia B
5) Rituximab to Treat Severe Hemophilia A
Hemophilia A
6) Kogenate Liplong Study - BAY 79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A
Hemophilia A
7) Hemophilia Inhibitor Genetics Study (HIGS)
Hemophilia A With Inhibitor
8) Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
Hemophilia B
9) Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A
Hemophilia A
10) Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds
Haemophilia A; Haemophilia B
11) Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery
Hemophilia A
12) Russian Kogenate Pediatric Study
Hemophilia A
13) Study Evaluating Allergic Reactions to Benefix in Hemophilia B Patients
Hemophilia B
14) Study Comparing On-Demand Treatment With Two Prophylaxis Regimens of BeneFIX in Patients With Severe Hemophilia B
Hemophilia B
15) Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia
Hemophilia A
16) Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult Subjects Compared to That of Episodic Treatment. (SPINART)
Hemophilia A
17) Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A
Hemophilia A
18) Genetic Susceptibility to Factor VIII Inhibitors
Hemophilia
19) A Prospective, Randomized, Cross-Over Study of an Activated Prothrombin Complex Concentrate for Secondary Prophylaxis in Patients With Hemophilia A and Inhibitors
Hemophilia A With Inhibitors
20) Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK of B-Domain Deleted Recombinant FVIII
Hemophilia A
|
|
|
